Phenylephrine “Not Significantly Different From” Placebo – Schering Study
This article was originally published in The Tan Sheet
Executive Summary
Schering-Plough released a study on phenylephrine's efficacy as compared to pseudoephedrine and placebo Oct. 31 that "raises even more questions" about the drug, according to Rep. Henry Waxman (D-Calif.)
You may also be interested in...
Data Support Phenylephrine Efficacy, But More Studies Needed – NDAC
FDA's Nonprescription Drugs Advisory Committee recommends additional studies on phenylephrine efficacy for treatment of nasal congestion, although members say current data support the efficacy of the OTC cough/cold ingredient
Data Support Phenylephrine Efficacy, But More Studies Needed – NDAC
FDA's Nonprescription Drugs Advisory Committee recommends additional studies on phenylephrine efficacy for treatment of nasal congestion, although members say current data support the efficacy of the OTC cough/cold ingredient
Data Support Phenylephrine Efficacy, But More Studies Needed – NDAC
FDA's Nonprescription Drugs Advisory Committee recommends additional studies on phenylephrine efficacy for treatment of nasal congestion, although members say current data support the efficacy of the OTC cough/cold ingredient